New Key Statistics Module, Z-Score and F-Score
NYSE:EBS Key Ratios
| Market Cap $ M | 203.80 |
| Enterprise Value $ M | 952.30 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.31 |
| Price/Sales | 0.19 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1,023.00 |
| EPS (TTM) $ | -14.76 |
| Beneish M-Score | -2.53 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.48 |
| EV-to-EBITDA | -1.84 |
| PEG | -- |
| Shares Outstanding M | 52.39 |
| Net Margin (%) | -73.96 |
| Operating Margin % | -19.73 |
| Pre-tax Margin (%) | -71.47 |
| Quick Ratio | 0.54 |
| Current Ratio | 1.04 |
| ROA % (ttm) | -31.52 |
| ROE % (ttm) | -77.37 |
| ROIC % (ttm) | -9.36 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.50 |
EBS Number of Guru Trades
EBS Volume of Guru Trades
Gurus Latest Trades with NYSE:EBS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:EBS is held by these investors
Total 2
Emergent BioSolutions Inc Insider Transactions
No Available Data
News about NYSE:EBS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers